Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL

NCT02394379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-11-13

No results posted yet for this study

Summary

To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

Trulign™ Toric IOL

Trulign™ Toric Posterior Chamber IOL is a modified plate haptic lens

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    collaborator INDUSTRY
  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric · Valeant Pharmaceuticals NA / Bausch & Lomb

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-19
Primary Completion
2019-08-05
Completion
2019-08-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02394379 on ClinicalTrials.gov